Sinovac Biotech Ltd. (SVA) at a glance

Sinovac Biotech Ltd. (SVA) is a small-cap company. It trades at $6.47, with a P/E of 6.7, a 67.9% profit margin and revenue growth of 183.6%. It does not pay a dividend. Vestovix scores it 74/100 overall. Its strongest dimension is Value (99/100) and its weakest is Income (40/100).

Price
$6.47
Market cap
$464.9M
P/E ratio
6.7
Dividend yield
None
Beta
n/a
52-week range
$6.47 to $6.47
Vestovix Score74/ 100How this works
Value
99
Growth
94
Income
40
Safety
66
Momentum
50